4 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Financial health
The company holds more cash ($280M) than total debt ($2M).
Operating income covered interest expense -104.2× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 5.9 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$24M
-$160M
14.3%
-251.2%
-78.3%
-32.1%
-$47M
$2M
$280M
2024
$4M
-$32M
38.6%
-636.0%
-67.7%
-34.4%
-$26M
$2M
$62M
2023
$433026
-$16M
32.1%
-3704.6%
-100.0%
-59.2%
-$8M
—
$8M
2022
$0
-$5M
—
—
-50.4%
-39.6%
-$7M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$5M
-$34M
28.9%
-667.5%
-12.8%
-5.9%
-$27M
$60M
$220M
Mar '26
$4M
-$7M
39.9%
-595.4%
-2.5%
-1.2%
-$24M
$58M
$207M
Dec '25
$17M
-$63M
12.5%
-150.2%
-31.0%
-12.7%
-$20M
$2M
$280M
Sep '25
$5M
-$13M
8.7%
-306.1%
-17.4%
-5.7%
-$12M
$14M
$114M
Jun '25
$1M
-$75M
47.7%
-999.1%
-297.9%
-55.3%
-$10M
—
$68M
Mar '25
$1M
-$8M
29.7%
-721.6%
-19.9%
-9.3%
-$5M
—
$56M
Dec '24
$1M
-$9M
50.7%
-640.7%
-19.3%
-9.8%
-$5M
$2M
$62M
Sep '24
$1M
-$7M
27.0%
-499.6%
-19.0%
-8.7%
-$9M
—
$52M
Jun '24
$1M
-$9M
41.2%
-729.5%
-80.7%
-16.2%
-$8M
—
—
Mar '24
$840354
-$7M
33.2%
-691.9%
-66.2%
-15.3%
-$4M
—
—
Dec '23
$433026
-$4M
32.1%
-929.1%
-25.6%
-15.1%
-$3M
—
$8M
Sep '23
$0
-$4M
—
—
-48.9%
-35.6%
-$1M
—
—
Jun '23
$0
-$4M
—
—
-42.2%
-33.6%
-$1M
—
—
Mar '23
$0
-$4M
—
—
-30.3%
-24.8%
-$2M
—
—
Dec '22
—
-$1M
—
—
-13.3%
-10.4%
-$2M
—
—
Sep '22
—
-$2M
—
—
-31.0%
-20.6%
-$3M
—
—
Jun '22
—
-$827170
—
—
-11.2%
—
-$2M
—
—
Mar '22
—
-$857588
—
—
-12.2%
—
-$1M
—
—
Dec '21
—
-$3M
—
—
-43.5%
-36.5%
-$4M
—
—
Valuation over time
How the market has priced ASPI against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 860.3× (Jan '24) to 25.1× (Sep '26).
The dividend yield has fallen from 0.4% (Dec '24) to 0.3% (Nov '25).
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is ASPI growing its revenue and profit?
See the revenue and net-income charts above for Asp Isotopes Inc.'s multi-year trend.
How much debt does ASPI have?
As of FY2025, Asp Isotopes Inc. reported $2M of total debt against $280M of cash; operating income covered interest expense -104.2×.
What is ASPI's profit margin?
In FY2025, gross margin was 14.3%, operating margin -251.2%, and net margin -670.2%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.